Valerie Pimpaneau, PhD Voisin Consulting Life Sciences

Valerie Pimpaneau received her PhD in Molecular and Cellular Biophysics at the University of Orleans in the field of lectins and glycoproteins and completed a post-doctoral program with Eli Lilly and Co. in Indianapolis where she worked on the quality assessment of recombinant glycoproteins.

Valerie continued to gain international experience within the bio-industry by joining Repligen and then Genzyme Corporation in Cambridge, Massachusetts where she handled responsibilities of analytical development and quality control for various biotechnology products. She later moved to Genzyme Flanders in Belgium where she participated in technical transfer of several bioprocesses and in the design of comparability plans.

In her current role, Valerie manages projects involving the development of CMC and quality strategies for Drugs, Biologics, Gene and Cell Therapy. She interfaces actively with the technical and regulatory teams to help coordinate all CMC activities in line with the product development phases. This includes preparation of regulatory submissions, interaction with agencies as well as development of CMC strategies and technical support.

Valerie has been a long term member of the PDA Europe ATMPs committee and PDA Cell & Gene Task Force.